Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Globus Med Inc (GMED)

595 + Investors. Track Smart Money conviction in GMED. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +42
Streak
2Q ▲
Buyers last Q
58%

Smart Money Signals — GMED

Based on 598 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added GMED than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
598 hedge funds hold GMED right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +18% more funds vs a year ago

fund count last 6Q
+90 new funds entered over the past year (+18% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 58% buying

337 buying245 selling
Last quarter: 337 funds bought or added vs 245 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-26 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 69 → 73 → 133 → 107. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

54% of holders stayed for 2+ years

■ 54% conviction (2yr+) ■ 21% medium ■ 26% new
322 out of 598 hedge funds have held GMED for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

92 → 69 → 73 → 133 → 107 new funds/Q
New funds entering each quarter: 69 → 73 → 133 → 107. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 59% of holders stayed 2+ years

■ 59% veterans ■ 14% 1-2yr ■ 27% new
Of 609 current holders: 360 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 43% AUM from top-100 funds

43% from top-100 AUM funds
58 of 598 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in GMED. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — GMED

In 2026 Q1, 337 hedge funds were net buyers of GMED (107 opened a new position, 230 added to an existing one), while 245 reduced or exited (180 trimmed, 65 sold completely) — a 58% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 43% of total institutional value in GMED is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +42 funds (more new holders than closures). Total institutional holders: 598.

Hedge Fund Ownership: GMED

How many hedge funds hold GMED — quarterly history vs. share price
Quarterly hedge fund ownership of GMED vs. share price

Market Analysis: GMED

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GMED

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Globus Med Inc (GMED) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much GMED has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
GMED
-6.7%
XLV
+4.9%

GMED outperformed XLV by -11.6% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
GMED
+4.9%
XLV
+6.0%

Since the filing became public, GMED outperformed XLV by -1.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

43 top-rated funds 9 high-conviction
Consensus
7.1
/ 10
breadth
×
Elite
5.6
/ 10
conviction
Hedge Fund Positioning: GMED
595 + Investors

Track Smart Money conviction in GMED. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 595 556 7.01%
13F Shares 103M 114M -8.89%
Total Value $8.56B $9.79B -12.58%
New Positions 106 133 -27
Increased Positions 224 145 +79
Closed Positions 67 56 +11
Reduced Positions 180 217 -37
Total Calls 7 13 -46.15%
Total Puts 5 10 -50.0%
PUT/CALL Ratio 0.71 0.77 Neutral

Statistics: GMED

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

595 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GMED. Verified SEC 13F-HR filings.

QUARTER:
Top 25 GMED holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Paradice Investment Management LLC 7.95% 491,265 $42.3M
2 Terril Brothers, INC. 7.57% 321,365 $27.7M
3 Hyperion Capital Advisors LP 5.84% 140,849 $12.1M
4 Pembroke Management, LTD 5.09% 408,539 $35.2M
5 Varenne Capital Partners 4.95% 236,615 $20.5M
6 Lightrock Netherlands B.V. 4.74% 257,242 $22.2M
7 Foresight Group Ltd Liability Partnership 4.47% 293,903 $25.3M
8 Defilade Capital Management, L.P. 4.29% 354,350 $30.5M
9 Parsifal Capital Management, LP 3.93% 387,117 $33.4M
10 Sirios Capital Management L P 3.70% 354,168 $30.5M
11 Global Alpha Capital Management Ltd. 3.60% 694,444 $59.8M
12 Geneva Capital Management LLC 3.22% 1,760,971 $151.7M
13 American Capital Management Inc 3.07% 663,049 $57.1M
14 Capital Impact Advisors, LLC 2.91% 83,678 $7.2M
15 Andrew Hill Investment Advisors, Inc. 2.81% 36,635 $3.2M
16 Paradigm Capital Management Inc/Ny 2.71% 822,299 $70.8M
17 Madison Avenue Partners, LP 2.69% 717,476 $61.8M
18 Soleus Capital Management, L.P. 2.55% 729,467 $62.9M
19 Conscious Wealth Investments, LLC 2.36% 44,807 $4.2M
20 Sterling Investment Advisors, Ltd. 2.25% 144,023 $12.4M
21 Broadhurst Jeffrey B 2.04% 23,053 $2.0M
22 Godshalk Welsh Capital Management, Inc. 2.00% 40,000 $3.4M
23 Bridge City Capital, LLC 1.58% 66,252 $5.7M
24 Future Fund LLC 1.58% 52,158 $4.5M
25 Anchor Capital Advisors LLC 1.57% 639,524 $55.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Globus Med Inc (GMED)

What does the Smart Money Trend signal show for GMED?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added GMED than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for GMED?

Slight buying edge — 58% buying: Last quarter: 337 funds bought or added vs 245 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for GMED holders?

Elite ownership — 43% AUM from top-100 funds: 58 of 598 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in GMED. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held GMED?

54% of holders stayed for 2+ years: 322 out of 598 hedge funds have held GMED for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Globus Med Inc (GMED) following the 2026 Q1 hedge fund 13F filings?

As of today, GMED has moved +4.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -1.1%. Since the quarter end (March 31, 2026), GMED has gained -6.7% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →